KinSea Lead Discovery Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 1

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $535K

  • Investors
  • 2

KinSea Lead Discovery General Information

Description

Developer of pharmaceutical compounds intended for therapeutic purposes. The company focuses on identifying and developing marine bioactive compounds from the Arctic Ocean, specifically leveraging chemistry to create drug candidates that include a pan-mutant FLT3 kinase inhibitor for acute myeloid leukemia, to overcome limitations of existing therapies and establish a diversified portfolio of high-potential drug candidates, enabling pharmaceutical market to access novel treatments for unmet medical needs.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • PostBox 6413 Stakkevollan
  • 9294 Tromso
  • Norway
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • PostBox 6413 Stakkevollan
  • 9294 Tromso
  • Norway

KinSea Lead Discovery Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

KinSea Lead Discovery Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Mar-2025 $535K Completed Generating Revenue
2. Seed Round 15-Mar-2024 Completed Generating Revenue
1. Seed Round 01-Mar-2023 Completed Generating Revenue
To view KinSea Lead Discovery’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

KinSea Lead Discovery Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

KinSea Lead Discovery Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation (Norway) Government
Khanu Management Venture Capital Minority
To view KinSea Lead Discovery’s complete investors history, request access »

KinSea Lead Discovery FAQs

  • When was KinSea Lead Discovery founded?

    KinSea Lead Discovery was founded in 2022.

  • Where is KinSea Lead Discovery headquartered?

    KinSea Lead Discovery is headquartered in Tromso, Norway.

  • What is the size of KinSea Lead Discovery?

    KinSea Lead Discovery has 1 total employees.

  • What industry is KinSea Lead Discovery in?

    KinSea Lead Discovery’s primary industry is Drug Discovery.

  • Is KinSea Lead Discovery a private or public company?

    KinSea Lead Discovery is a Private company.

  • What is KinSea Lead Discovery’s current revenue?

    The current revenue for KinSea Lead Discovery is .

  • Who are KinSea Lead Discovery’s investors?

    Innovation (Norway) and Khanu Management have invested in KinSea Lead Discovery.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process